Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon

P. Farci, P. Karayiannis, M. G. Brook, A. Smedile, M. E. Lai, A. Balestrieri, J. A. Saldanha, J. Monjardino, J. Gerin, H. C. Thomas

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Ten patients with evidence of continuing HDV replication were treated with lymphoblastoid alpha-interferon and eight more were followed as a non-randomized control group. Four out of eight patients who completed one year of follow-up had cleared HDV-RNA from the serum whilst none of the control group did so. In these four responding cases there was a transient increase in transaminase levels during treatment and in two, this was followed by improvement. One patient also cleared HBV and seroconverted to anti-HBs (antibody to hepatitis B surface antigen - HBsAg). In one patient with sustained loss of HDV, recurrence of HDV infection was detected 18 months after completion of treatment.These data suggest that alpha-interferon can inhibit HDV replication in the short term but relapse after one to two years may occur. Inhibition of HDV-RNA is associated with improvement in the inflammatory liver disease and now larger studies are required to determine whether it influences survival.

Original languageEnglish
Pages (from-to)1045-1054
Number of pages10
JournalQJM
Volume73
Issue number2
DOIs
Publication statusPublished - 1989

Fingerprint

Hepatitis D
Hepatitis Delta Virus
Virus Diseases
Chronic Hepatitis
Interferon-alpha
Hepatitis B Surface Antigens
RNA
Recurrence
Control Groups
Therapeutics
Transaminases
Liver Diseases
Anti-Idiotypic Antibodies
Survival
Infection
Serum

Cite this

Farci, P. ; Karayiannis, P. ; Brook, M. G. ; Smedile, A. ; E. Lai, M. ; Balestrieri, A. ; Saldanha, J. A. ; Monjardino, J. ; Gerin, J. ; Thomas, H. C. / Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon. In: QJM. 1989 ; Vol. 73, No. 2. pp. 1045-1054.
@article{5fbc44ebaaa84d808d6e52543c794907,
title = "Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon",
abstract = "Ten patients with evidence of continuing HDV replication were treated with lymphoblastoid alpha-interferon and eight more were followed as a non-randomized control group. Four out of eight patients who completed one year of follow-up had cleared HDV-RNA from the serum whilst none of the control group did so. In these four responding cases there was a transient increase in transaminase levels during treatment and in two, this was followed by improvement. One patient also cleared HBV and seroconverted to anti-HBs (antibody to hepatitis B surface antigen - HBsAg). In one patient with sustained loss of HDV, recurrence of HDV infection was detected 18 months after completion of treatment.These data suggest that alpha-interferon can inhibit HDV replication in the short term but relapse after one to two years may occur. Inhibition of HDV-RNA is associated with improvement in the inflammatory liver disease and now larger studies are required to determine whether it influences survival.",
author = "P. Farci and P. Karayiannis and Brook, {M. G.} and A. Smedile and {E. Lai}, M. and A. Balestrieri and Saldanha, {J. A.} and J. Monjardino and J. Gerin and Thomas, {H. C.}",
year = "1989",
doi = "10.1093/oxfordjournals.qjmed.a068391",
language = "English",
volume = "73",
pages = "1045--1054",
journal = "QJM",
issn = "1460-2725",
publisher = "Oxford University Press",
number = "2",

}

Farci, P, Karayiannis, P, Brook, MG, Smedile, A, E. Lai, M, Balestrieri, A, Saldanha, JA, Monjardino, J, Gerin, J & Thomas, HC 1989, 'Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon', QJM, vol. 73, no. 2, pp. 1045-1054. https://doi.org/10.1093/oxfordjournals.qjmed.a068391

Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon. / Farci, P.; Karayiannis, P.; Brook, M. G.; Smedile, A.; E. Lai, M.; Balestrieri, A.; Saldanha, J. A.; Monjardino, J.; Gerin, J.; Thomas, H. C.

In: QJM, Vol. 73, No. 2, 1989, p. 1045-1054.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Treatment of chronic hepatitis delta virus (Hdv) infection with human lymphoblastoid alpha interferon

AU - Farci, P.

AU - Karayiannis, P.

AU - Brook, M. G.

AU - Smedile, A.

AU - E. Lai, M.

AU - Balestrieri, A.

AU - Saldanha, J. A.

AU - Monjardino, J.

AU - Gerin, J.

AU - Thomas, H. C.

PY - 1989

Y1 - 1989

N2 - Ten patients with evidence of continuing HDV replication were treated with lymphoblastoid alpha-interferon and eight more were followed as a non-randomized control group. Four out of eight patients who completed one year of follow-up had cleared HDV-RNA from the serum whilst none of the control group did so. In these four responding cases there was a transient increase in transaminase levels during treatment and in two, this was followed by improvement. One patient also cleared HBV and seroconverted to anti-HBs (antibody to hepatitis B surface antigen - HBsAg). In one patient with sustained loss of HDV, recurrence of HDV infection was detected 18 months after completion of treatment.These data suggest that alpha-interferon can inhibit HDV replication in the short term but relapse after one to two years may occur. Inhibition of HDV-RNA is associated with improvement in the inflammatory liver disease and now larger studies are required to determine whether it influences survival.

AB - Ten patients with evidence of continuing HDV replication were treated with lymphoblastoid alpha-interferon and eight more were followed as a non-randomized control group. Four out of eight patients who completed one year of follow-up had cleared HDV-RNA from the serum whilst none of the control group did so. In these four responding cases there was a transient increase in transaminase levels during treatment and in two, this was followed by improvement. One patient also cleared HBV and seroconverted to anti-HBs (antibody to hepatitis B surface antigen - HBsAg). In one patient with sustained loss of HDV, recurrence of HDV infection was detected 18 months after completion of treatment.These data suggest that alpha-interferon can inhibit HDV replication in the short term but relapse after one to two years may occur. Inhibition of HDV-RNA is associated with improvement in the inflammatory liver disease and now larger studies are required to determine whether it influences survival.

UR - http://www.scopus.com/inward/record.url?scp=0024466080&partnerID=8YFLogxK

U2 - 10.1093/oxfordjournals.qjmed.a068391

DO - 10.1093/oxfordjournals.qjmed.a068391

M3 - Article

C2 - 2623137

AN - SCOPUS:0024466080

VL - 73

SP - 1045

EP - 1054

JO - QJM

JF - QJM

SN - 1460-2725

IS - 2

ER -